Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes

Journal of Managed Care & Specialty Pharmacy (JMCP)

May 8, 2024

Related news

In the news

May 8, 2024

Meet the Board: Navigating the Evolving Landscape of Healthcare Coverage and Pharmacy Benefits with Marci Chodroff of Magellan, Prime Therapeutics

Managed Healthcare Executive: This month's episode of the Meet the Board podcast features a new member of our editorial advisory board, Marci J. Chodroff, MD, FACP, vice president of Medical Affairs at Magellan Rx Management, a Prime Therapeutics company

In the news

April 24, 2024

AMCP 2024: Key Takeaways From Leading Speakers

American Journal of Managed Care (AJMC): Session speakers at the Academy of Managed Care Pharmacy (AMCP) 2024 annual conference share their favorite parts of the event and the key takeaways they will leave the conference with

In the news

April 23, 2024

Award-Winning Poster Presentations From AMCP 2024

American Journal of Managed Care (AJMC): At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality